Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals
Articolo
Data di Pubblicazione:
2019
Abstract:
Despite the dramatic improvement in viral eradication rates that has been reached with direct antiviral agents (DAAs), the real benefit of viral eradication after DAAs on hepatocellular carcinoma (HCC) development is still controversial.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Cirrhosis; Direct antiviral agents; HCV; Hepatocellular carcinoma; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Disease Progression; Female; Hepatitis C, Chronic; Humans; Italy; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; alpha-Fetoproteins; Sustained Virologic Response
Elenco autori:
Lleo, A; Aglitti, A; Aghemo, A; Maisonneuve, P; Brunoa, S; Persico, M; Rendina, M; Ciancio, A; Lampertico, P; Brunetto, Mr; Di Marco, V; Zuin, M; Andreone, P; Villa, E; Troshina, G; Degasperi, E; Coco, B; Calvaruso, V; Giorgini, Am; Conti, F; Di Leo, A; Marzi, U; Boccaccio, V; Bollani, S; Colombo, M; Marzi, L
Link alla scheda completa:
Pubblicato in: